Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes - PubMed (original) (raw)
Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes
Mary Rieck et al. J Immunol. 2007.
Abstract
A variant of the PTPN22 gene, 1858C/T, is associated with an increased risk for the development of a wide array of autoimmune disorders. It is known that the protein tyrosine phosphatase Lyp encoded by this gene has an inhibitory effect on the proximal TCR signaling pathways. However, the consequences of carrying this variant and the mechanism by which it contributes to the development of autoimmunity are poorly understood. In this study, we demonstrate that homozygosity for this variant results in a profound deficit in T cell responsiveness to Ag stimulation. Heterozygosity for the variant allele is associated with reduced responsiveness of CD4+ memory T cells, characterized by diminished calcium mobilization, expression of CD25, and IL-10 production upon TCR stimulation. Additionally, the presence of the variant allele is associated with an increase in circulating memory T cells. We further demonstrate that these effects are not limited to the T cell compartment. Individuals with the variant allele have fewer memory B cells and these cells display a reduced response to stimulation via the BCR indicative of a B cell intrinsic defect. By identifying an immunologic phenotype in healthy subjects which correlates with the PTPN22 1858C/T genotype, we can now explore specific hypotheses regarding pathogenesis of diseases associated with the PTPN22 1858T variant.
Similar articles
- Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.
Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A, Buckner JH. Arechiga AF, et al. J Immunol. 2009 Mar 15;182(6):3343-7. doi: 10.4049/jimmunol.0713370. J Immunol. 2009. PMID: 19265110 Free PMC article. - Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2.
Bray C, Wright D, Haupt S, Thomas S, Stauss H, Zamoyska R. Bray C, et al. Front Immunol. 2018 Nov 12;9:2595. doi: 10.3389/fimmu.2018.02595. eCollection 2018. Front Immunol. 2018. PMID: 30483260 Free PMC article. - Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).
Chew GY, Sinha U, Gatenby PA, DeMalmanche T, Adelstein S, Garsia R, Hissaria P, French MA, Wilson A, Whittle B, Kirkpatrick P, Riminton DS, Fulcher DA, Cook MC. Chew GY, et al. J Allergy Clin Immunol. 2013 Apr;131(4):1130-5, 1135.e1. doi: 10.1016/j.jaci.2012.06.023. Epub 2012 Jul 31. J Allergy Clin Immunol. 2013. PMID: 22857794 - PTPN22: setting thresholds for autoimmunity.
Gregersen PK, Lee HS, Batliwalla F, Begovich AB. Gregersen PK, et al. Semin Immunol. 2006 Aug;18(4):214-23. doi: 10.1016/j.smim.2006.03.009. Epub 2006 May 30. Semin Immunol. 2006. PMID: 16731003 Review. - The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E, Palombi M, Fierabracci A. Gianchecchi E, et al. Autoimmun Rev. 2013 May;12(7):717-25. doi: 10.1016/j.autrev.2012.12.003. Epub 2012 Dec 20. Autoimmun Rev. 2013. PMID: 23261816 Review.
Cited by
- Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22.
Cerosaletti K, Buckner JH. Cerosaletti K, et al. Rev Diabet Stud. 2012 Winter;9(4):188-200. doi: 10.1900/RDS.2012.9.188. Epub 2012 Dec 28. Rev Diabet Stud. 2012. PMID: 23804260 Free PMC article. Review. - Taming lupus-a new understanding of pathogenesis is leading to clinical advances.
Liu Z, Davidson A. Liu Z, et al. Nat Med. 2012 Jun 6;18(6):871-82. doi: 10.1038/nm.2752. Nat Med. 2012. PMID: 22674006 Free PMC article. Review. - DNA-reactive B cells in lupus.
Suurmond J, Calise J, Malkiel S, Diamond B. Suurmond J, et al. Curr Opin Immunol. 2016 Dec;43:1-7. doi: 10.1016/j.coi.2016.07.002. Epub 2016 Aug 6. Curr Opin Immunol. 2016. PMID: 27504587 Free PMC article. Review. - Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
Meffre E, O'Connor KC. Meffre E, et al. Immunol Rev. 2019 Nov;292(1):90-101. doi: 10.1111/imr.12821. Epub 2019 Nov 12. Immunol Rev. 2019. PMID: 31721234 Free PMC article. Review. - The interferon-alpha signature of systemic lupus erythematosus.
Obermoser G, Pascual V. Obermoser G, et al. Lupus. 2010 Aug;19(9):1012-9. doi: 10.1177/0961203310371161. Lupus. 2010. PMID: 20693194 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials